Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: Initial experience with intracoronary tenecteplase

Catheterization and Cardiovascular Interventions

Volumn 66, Issue 3, 2005, Pages 327-332

  Kelly, Robert V ^a   Crouch, Eron ^a   Krumnacher, Heather ^a   Cohen, Mauricio G ^a   Stouffer, George A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Distal embolization; Intracoronary thrombus; No reflow; Percutaneous coronary intervention; Thrombolytic therapy

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPTIFIBATIDE; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; TENECTEPLASE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CAUCASIAN; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DRUG SAFETY; DRUG TOLERABILITY; EMBOLISM; FEMALE; HEART INFARCTION; HEMATOCRIT; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; ST SEGMENT ELEVATION; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 27644519366     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20521     Document Type: Article

References (14)

1. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 1992;326:287-291.
2. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
3. Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Hjemdahl-Monsen CE, Myler RK. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina trial. Circulation 1994;90:69-77.
4. Benedict CR, Refino CJ, Keyt BA, Pakala R, Paoni NF, Thomas GR, Bennett WF. New variant of human tissue plasminogen activator (TPA) with enhanced efficacy and lower incidence of bleeding compared with recombinant human TPA. Circulation 1995;92:3032-3040.
5. Keyt BA, Paoni NF, Refino CJ, Berleau L, Nguyen H, Chow A, Lai J, Pena L, Pater C, Ogez J. A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci USA 1994;91:3670-3674.
6. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999;354:716-722.
7. Saito T, Taniguchi I, Nakamura S, Oka H, Mizuno Y, Noda K, Yamashita S, Oshima S. Pulse-spray thrombolysis in acutely obstructed coronary artery in critical situations. Cathet Cardiovasc Diagn 1997;40:101-108.
8. TIMI study group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-627.
9. Schieman G, Cohen BM, Kozina J, Erickson JS, Podolin RA, Peterson KL, Ross J Jr, Buchbinder M. Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. Circulation 1990;82:2052-2060.
10. DeNardo SJ, Morris NB, Rocha-Singh KJ, Curtis GP, Rubenson DS, Teirstein PS. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts. Am J Cardiol 1995;76:776-780.
11. Hartmann JR, McKeever LS, Stamato NJ, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Cahill JM, Enger EL. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up. J Am Coll Cardiol 1991;18:1517-1523.
12. Hasdai D, Garratt KN, Holmes DR Jr, Berger PB, Schwartz RS, Bell MR. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 1996;28:361-367.
13. Zidar FJ, Kaplan BM, O'Neill WW, Jones DE, Schreiber TL, Safian RD, Ajluni SC, Sobolski J, Timmis GC, Grines CL. Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteries. J Am Coll Cardiol 1996;27:1406-1412.
14. Intracoronary t-PA registry investigators. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry. Cathet Cardiovasc Diagn 1995;34:196-201.